PanTum® Detect is a multi-tumor screening blood test that measures levels of two biomarker enzymes present within your immune cells (macrophages). If the enzyme levels are raised the test is positive.

PanTum® Detect test detects the presence of two enzymes in whole human blood, which are increasingly formed in most solid tumors – even in the early, asymptomatic phase. The two biomarker enzymes are called TKTL1 and Apo10.

TKTL1 provides an indication of switch towards invasive growth. TKTL1 regulates anaerobic glucose metabolism (Warburg effect) which is fermentation of glucose using the Pentose Phosphate Pathway resulting in the formation of lactic acid and breakdown of collagen matrix leading to metastasis

Elevated concentrations of DNaseX (Apo10) enzyme shows a disruption of programmed cell death (Apoptosis). It provides indication of tumor proliferation.

No, the test does not show the type, spread, or location of cancer. PanTum® Detect is a screening blood test and a positive result indicates the presence of a tumor/s if the levels of two biomarker enzymes are raised. If the test is positive, follow-up diagnostics are carried out using standard tumor markers, imaging and PET/CT and Histopathology for further diagnosis.

No, the test does not show the type, spread, or location of cancer.

PanTum® Detect is a blood test for screening healthy individuals for the presence of two biomarker enzymes inside immune cells (macrophages) circulating in an individual’s bloodstream.

A positive result indicates the presence of silently growing benign, premalignant and malignant tumors somewhere in the body.

If the test is positive, follow-up diagnostics are carried out using standard tumor markers, imaging, PET/CT and Histopathology to confirm the location and spread of the silently growing tumors.

The “Cancer-Scan” program combines PanTum® Detect screening blood tests with existing pathology and imaging techniques into an integrated multi-tumor screening concept for the early detection of pre-cancerous and cancerous tumors in symptomless stages for healthy individuals.